KMT2D, a key factor in driving cellular transformation and influencing therapeutic response across cancer lineages.

Sahu P, Lee YT, Karatza A, Tan YJ, Huang HY, So J, Wong KK

Open source

DOI
10.1016/j.critrevonc.2026.105605
Published
2026 Sep 17
Container
Critical reviews in oncology/hematology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.critrevonc.2026.105605,
  title = {KMT2D, a key factor in driving cellular transformation and influencing therapeutic response across cancer lineages.},
  author = {Sahu P and Lee YT and Karatza A and Tan YJ and Huang HY and So J and Wong KK},
  year = {2026},
  journal = {Critical reviews in oncology/hematology},
  doi = {10.1016/j.critrevonc.2026.105605},
  url = {https://doi.org/10.1016/j.critrevonc.2026.105605}
}

RIS

TY  - JOUR
TI  - KMT2D, a key factor in driving cellular transformation and influencing therapeutic response across cancer lineages.
AU  - Sahu P
AU  - Lee YT
AU  - Karatza A
AU  - Tan YJ
AU  - Huang HY
AU  - So J
AU  - Wong KK
PY  - 2026
JO  - Critical reviews in oncology/hematology
DO  - 10.1016/j.critrevonc.2026.105605
UR  - https://doi.org/10.1016/j.critrevonc.2026.105605
ER  - 

APA

P, S., YT, L., A, K., YJ, T., HY, H., J, S., & KK, W. (2026). KMT2D, a key factor in driving cellular transformation and influencing therapeutic response across cancer lineages.. Critical reviews in oncology/hematology. https://doi.org/10.1016/j.critrevonc.2026.105605

Source records